Ann Lab Med.  2016 Mar;36(2):162-165. 10.3343/alm.2016.36.2.162.

Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital

Affiliations
  • 1Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea. deyong@yuhs.ac
  • 2Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Carbapenemase-producing organisms (CPO) are rapidly disseminating worldwide, and their presence in tertiary care hospitals poses a significant threat to the management of nosocomial infections. There is a need to control CPO, especially in intensive care unit (ICU) patients, because these organisms are resistant to most beta-lactam antibiotics and are easily transmitted. At present, the identification of CPO is time-consuming; hence, this study focused on the use of the Xpert CARBA-R assay (Cepheid, USA) to determine intestinal colonization rates of CPO in patients admitted to the ICU of a tertiary care hospital in Korea. Forty clinical stool samples were collected and inoculated both in a CARBA-R cartridge and in conventional culture plates. The CARBA-R assay required only ~one hour to screen CPO, while the time required for conventional culture was over three days. We also found that the prevalences of intestinal colonization by carbapenem-resistant organisms and Enterobacteriaceae were 17.5% (7 out of 40) and 7.5% (3 out of 40), respectively. Among the colonizing strains, three that contained carbapenemase, including Klebsiella pneumonia carbapenemase (KPC), and imipenem (IMP) and Verona integron-mediated metallo-beta-lactamase (VIM) were found. With its convenience, the Xpert CARBA-R assay can be included in CPO surveillance strategies.

Keyword

Carbapenemase-producing organisms; Carbapenem-resistant organisms; Intensive care unit; Colonization; Xpert CARBA-R

MeSH Terms

Anti-Bacterial Agents/pharmacology
Bacterial Proteins/*genetics/metabolism
DNA, Bacterial/analysis
Drug Resistance, Multiple, Bacterial/genetics
Enterobacteriaceae/drug effects/genetics/*isolation & purification
Feces/microbiology
Humans
Imipenem/pharmacology
Intensive Care Units
Klebsiella pneumoniae/drug effects/genetics/*isolation & purification
Reagent Kits, Diagnostic
Real-Time Polymerase Chain Reaction
Republic of Korea
Tertiary Healthcare
beta-Lactamases/*genetics/metabolism
Anti-Bacterial Agents
Bacterial Proteins
DNA, Bacterial
Imipenem
Reagent Kits, Diagnostic
beta-Lactamases

Cited by  4 articles

Positivity of Carbapenemase-producing Enterobacteriaceae in Patients Following Exposure within Long-term Care Facilities in Seoul, Korea
Jin Ju Park, Yu Bin Seo, Jacob Lee, Joong Sik Eom, Wonkeun Song, Young Kyun Choi, Sung Ran Kim, Hee Jung Son, Nan Hyoung Cho
J Korean Med Sci. 2020;35(36):e303.    doi: 10.3346/jkms.2020.35.e303.

Prevalence and Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study
Jin Suk Kang, Jongyoun Yi, Mee Kyung Ko, Soon Ok Lee, Jeong Eun Lee, Kye-Hyung Kim
J Korean Med Sci. 2019;34(18):.    doi: 10.3346/jkms.2019.34.e140.

Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea
Hyo-Jin Lee, Jae-Ki Choi, Sung-Yeon Cho, Si-Hyun Kim, Sun Hee Park, Su-Mi Choi, Dong-Gun Lee, Jung-Hyun Choi, Jin-Hong Yoo
Infect Chemother. 2016;48(3):166-173.    doi: 10.3947/ic.2016.48.3.166.

Prevalence and Risk Factors for Carbapenem-Resistant Enterobacteriaceae Colonization in Patients with Stroke
Yong Hyun Han, Min Joon Bae, Yang Rok Hur, Kihun Hwang
Brain Neurorehabil. 2019;12(2):.    doi: 10.12786/bn.2019.12.e16.


Reference

1. Yong D, Shin HB, Kim YK, Cho J, Lee WG, Ha GY, et al. Increase in the prevalence of carbapenem-resistant Acinetobacter isolates and ampicillin-resistant non-typhoidal Salmonella species in Korea: a KONSAR Study Conducted in 2011. Infect Chemother. 2014; 46:84–93. PMID: 25024870.
2. Chung HS, Lee Y, Park ES, Lee DS, Ha EJ, Kim M, et al. Characterization of the multidrug-resistant Acinetobacter species causing a nosocomial outbreak at intensive care units in a Korean Teaching Hospital: suggesting the correlations with the clinical and environmental samples, including respiratory tract-related instruments. Ann Clin Microbiol. 2014; 17:29–34.
3. Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin Infect Dis. 2000; 31:1119–1125. PMID: 11073738.
4. Gregory CJ, Llata E, Stine N, Gould C, Santiago LM, Vazquez GJ, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol. 2010; 31:476–484. PMID: 20334553.
5. Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother. 2004; 48:4793–4799. PMID: 15561858.
6. Gibb AP, Tribuddharat C, Moore RA, Louie TJ, Krulicki W, Livermore DM, et al. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7). Antimicrob Agents Chemother. 2002; 46:255–258. PMID: 11751148.
7. Tokatlidou D, Tsivitanidou M, Pournaras S, Ikonomidis A, Tsakris A, Sofianou D. Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital. J Clin Microbiol. 2008; 46:1005–1008. PMID: 18199780.
8. Wrenn C, O'Brien D, Keating D, Roche C, Rose L, Ronayne A, et al. Investigation of the first outbreak of OXA-48-producing Klebsiella pneumoniae in Ireland. J Hosp Infect. 2014; 87:41–46. PMID: 24746608.
9. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control. 2012; 40:421–425. PMID: 21906844.
10. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014; 20(Suppl 1):1–55. PMID: 24329732.
Article
11. Kim J, Lee JY, Kim SI, Song W, Kim JS, Jung S, et al. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med. 2014; 34:20–25. PMID: 24422191.
12. Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control. 2014; 42:e61–e64. PMID: 24773806.
13. Tenover FC, Canton R, Kop J, Chan R, Ryan J, Weir F, et al. Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay. J Clin Microbiol. 2013; 51:3780–3787. PMID: 24006011.
Article
14. Song W, Hong SG, Yong D, Jeong SH, Kim HS, Kim HS, et al. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp. Ann Lab Med. 2015; 35:212–219. PMID: 25729723.
15. Lee W, Chung HS, Lee Y, Yong D, Jeong SH, Lee K, et al. Comparison of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry assay with conventional methods for detection of IMP-6, VIM-2, NDM-1, SIM-1, KPC-1, OXA-23, and OXA-51 carbapenemase-producing Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 2013; 77:227–230. PMID: 23993215.
16. Park YJ, Song W. Strategies for interpretive standards of β-lactams susceptibility testing and identification of extended-spectrum β-lactamases and carbapenemases in Enterobacteriaceae. Ann Clin Microbiol. 2013; 16:111–119.
17. Seah C, Low DE, Patel SN, Melano RG. Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae. J Clin Microbiol. 2011; 49:1965–1969. PMID: 21430097.
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility tsting. M100-S24. Wayne, PA: Clinical and Laboratory Standards Institues;2014.
19. Decousser JW, Poirel L, Desroches M, Jayol A, Denamur E, Nordmann P. Failure to detect carbapenem-resistant Escherichia coli producing OXA-48-like using the Xpert Carba-R assay. Clin Microbiol Infect. 2015; 21:e9–e10. PMID: 25682281.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr